货号:A296504
同义名:
Isaconitine; Pikraconitin
Benzoylaconine是一种从五加科植物中分离的三萜皂苷,具有抗炎、抗肿瘤和抗菌活性,并通过诱导自噬和凋亡作用发挥抗癌效应。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Benzoylaconine is an alkaloid in the Chinese traditional medicine Radix Aconiti Lateralis Preparata (Fuzi). |
| Concentration | Treated Time | Description | References | |
| C2C12 cells | 20 μM-60 μM | 1 hour | To evaluate the protective effect of BAC on H/R-induced C2C12 cell injury. Results showed that BAC dose-dependently enhanced cell viability, reduced CK and LDH levels, decreased ROS generation, and increased SOD activity. | Drug Des Devel Ther. 2024 Jun 10;18:2125-2142 |
| HaCaT keratinocytes | 0, 10, 20, 40 μM | 24 h | To evaluate the effects of BAC on TNF-α/LPS-induced proliferation and inflammatory cytokine release in HaCaT cells. Results showed that BAC inhibited keratinocyte proliferation in a dose-dependent manner and reduced the expression of IL-6, IL-8, TNF-α, and IL-17. | Molecules. 2023 May 31;28(11):4473 |
| Caco-2 cells | 50 μM | 6 days | To evaluate the effect of BAC on P-gp expression. Results showed that BAC at 50 μM significantly increased P-gp protein levels, with effects intermediate between AC and aconine. | Sci Rep. 2016 May 3;6:25343 |
| HepG2 cells | 25, 50, 75 μM | 2 days | BAC dose-dependently increased mitochondrial mass, mtDNA copy number, cellular ATP production, and the expression of OXPHOS-related proteins. | Acta Pharmacol Sin. 2019 May;40(5):658-665 |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley rats | Femoral artery ligation and reperfusion-induced skeletal muscle ischemia-reperfusion injury model | Intraperitoneal injection | 5 mg/kg, 10 mg/kg, 20 mg/kg | Single administration before reperfusion | To evaluate the protective effect of BAC on skeletal muscle ischemia-reperfusion injury. Results showed that BAC dose-dependently alleviated muscle tissue damage, reduced tissue edema (W/D ratio), decreased serum CK and LDH levels, increased SOD activity, reduced MDA levels, and decreased apoptosis. | Drug Des Devel Ther. 2024 Jun 10;18:2125-2142 |
| C57BL/6 mice | IMQ-induced psoriasis-like skin inflammation model | Oral administration | 1 mg/kg and 3 mg/kg | Consecutive 6 days | To evaluate the therapeutic effects of BAC on IMQ-induced psoriasis-like skin inflammation in mice. Results showed that BAC significantly alleviated skin lesion symptoms, including scales, thickness, and erythema, and reduced the accumulation of Th17 cells and the release of inflammatory cytokines. | Molecules. 2023 May 31;28(11):4473 |
| SD rats | Cardiac function evaluation model | Intravenous injection | 2 mg/kg | Single dose, recorded for 30 minutes | To evaluate the effect of Benzoylaconine on cardiac function, results showed that Benzoylaconine weakened cardiac function, as represented by decreased LVSP and +dp/dt max, and increased LVEDP | J Pharm Anal. 2017 Jun;7(3):170-175 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.66mL 0.33mL 0.17mL |
8.28mL 1.66mL 0.83mL |
16.56mL 3.31mL 1.66mL |
|
| CAS号 | 466-24-0 |
| 分子式 | C32H45NO10 |
| 分子量 | 603.7 |
| SMILES Code | O([C@H]1C[C@H]([C@]2(CN(C3C4[C@]5([C@H]([C@@H]([C@@]6(C([C@H]5[C@@]([H])(C6)C31[C@]2([H])[C@H]4OC)OC(C1C=CC=CC=1)=O)O)OC)O)O)CC)COC)O)C |
| MDL No. | MFCD01704309 |
| 别名 | Isaconitine; Pikraconitin; Benzoylaconitine |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 55 mg/mL(91.1 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1